Reverting Colitis Symptoms by Oral Administration of L. reuteri Expressing CXCL12 Acting Through Novel Pathway Demonstrated in Two Experimental Animal Models

Published in

FASEB Journal
2022, volume: 36, number: S1
Publisher: FASEB

Conference

Experimental biology meeting, April 2-5 2022, Philadelphia, US

SLU Authors

• Roos, Stefan

  • Department of Molecular Sciences, Swedish University of Agricultural Sciences
    

UKÄ Subject classification

Pharmacology and Toxicology

Publication identifier

• DOI: https://doi.org/10.1096/fasebj.2022.36.S1.L7872

Permanent link to this page (URI)

https://res.slu.se/id/publ/126737